Patent ID: 7704957
Filing Date: 2010-04-27
Classification: A61K,A61P

Abstract:
1. A method of inhibiting HIV activity comprising administering to a subject in need of same an HIV-inhibiting amount of 3-[5-(methoxy-ethyl)-3,6-dioxo-piperazine-2-yl]propionic acid, as represented by the following Formula 1, and 4-methyl-2-[(pyrrolidine-2-carbonyl)-2-amino]pentanoic acid, as represented by the following Formula 2 wherein 3-[5-(methoxy-ethyl)-3,6-dioxo-piperazine-2-yl]propionic acid and 4-methyl-2-[(pyrrolidine-2-carbonyl)-2-amino]pentanoic acid are purified, or are obtained by organic synthesis.